Molecular biology. miRNAs in neurodegeneration

scientific article published on 01 August 2007

Molecular biology. miRNAs in neurodegeneration is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1126/SCIENCE.1148530
P698PubMed publication ID17761871

P50authorSébastien S. HébertQ42384154
P2093author name stringBart De Strooper
P433issue5842
P407language of work or nameEnglishQ1860
P921main subjectmolecular biologyQ7202
neurodegenerationQ1755122
P1104number of pages2
P304page(s)1179-1180
P577publication date2007-08-01
P1433published inScienceQ192864
P1476titleMolecular biology. miRNAs in neurodegeneration
P478volume317

Reverse relations

cites work (P2860)
Q50015658A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia.
Q35070572A novel X-linked four-repeat tauopathy with Parkinsonism and spasticity
Q39687917A search for SNCA 3' UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease.
Q37122270A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls.
Q36429533Barcoded cDNA library preparation for small RNA profiling by next-generation sequencing
Q37352375Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus
Q58790362Crosstalk between MicroRNAs and Autophagy in Adult Neurogenesis: Implications for Neurodegenerative Disorders
Q98778829Effect of Moxibustion on Behavioral Changes and Expression of APP and BACE1 in Hippocampus of SAMP8 Mice
Q24657549Epigenetic principles and mechanisms underlying nervous system functions in health and disease
Q36211443Exosome-mediated shuttling of microRNA-29 regulates HIV Tat and morphine-mediated neuronal dysfunction.
Q21129257Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?
Q38212483Expression and function of growth hormone in the nervous system: a brief review.
Q38340344Fabrication of a Structure‐Specific RNA Binder for Array Detection of Label‐Free MicroRNA
Q40209615Genetic Variants in MicroRNAs and Their Binding Sites Are Associated with the Risk of Parkinson Disease
Q64240282Genetics and epigenetics of autism spectrum disorder-current evidence in the field
Q27320372Genome-wide analysis of miRNA signature in the APPswe/PS1ΔE9 mouse model of alzheimer's disease
Q33604717Genomic features of the human dopamine transporter gene and its potential epigenetic States: implications for phenotypic diversity
Q48040725Identification of regulatory relationships in Parkinson's disease
Q35208140In situ hybridization is a necessary experimental complement to microRNA (miRNA) expression profiling in the human brain
Q55346192Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson's disease.
Q47959536Loss of MicroRNA-7 Regulation Leads to α-Synuclein Accumulation and Dopaminergic Neuronal Loss In Vivo
Q36609033Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression
Q38009700Mechanism(s) of alteration of micro RNA expressions in Huntington's disease and their possible contributions to the observed cellular and molecular dysfunctions in the disease
Q47214829MicroRNA expression patterns in human anterior cingulate and motor cortex: A study of dementia with Lewy bodies cases and controls.
Q37617954MicroRNA implications across neurodevelopment and neuropathology
Q36254253MicroRNA-146a rs2910164 is associated with severe preeclampsia in Black South African women on HAART.
Q37251978MicroRNA-431 regulates axon regeneration in mature sensory neurons by targeting the Wnt antagonist Kremen1.
Q38202497MicroRNAs and Molecular Mechanisms of Neurodegeneration.
Q37728116MicroRNAs and deregulated gene expression networks in neurodegeneration
Q41547602MicroRNAs as newer therapeutic targets: A big hope from a tiny player
Q38843644MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?
Q38073708MicroRNAs in the brain: it's regulatory role in neuroinflammation
Q38325601Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression
Q38095915Molecular mechanisms of peripheral nerve regeneration: emerging roles of microRNAs
Q34363395Multiplexed detection and label-free quantitation of microRNAs using arrays of silicon photonic microring resonators
Q45338683Mutational screening of PARKIN identified a 3' UTR variant (rs62637702) associated with Parkinson's disease.
Q24650444Nanotechnology, nanotoxicology, and neuroscience
Q44926381Non-coding RNA as a trigger of neuropathologic disorder phenotypes in transgenic Drosophila
Q92333102Nrf2-regulated miR-380-3p blocks the translation of Sp3 protein and its mediation of paraquat-induced toxicity in mouse neuroblastoma N2a cells
Q33966769RNA-ligase-dependent biases in miRNA representation in deep-sequenced small RNA cDNA libraries
Q37134134Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics
Q31104534Significance of miR-196b in tumor-related epilepsy of patients with gliomas
Q36796402Specification of neural cell fate and regulation of neural stem cell proliferation by microRNAs
Q33722837The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1.
Q26858788The involvement of microRNAs in neurodegenerative diseases
Q24608620The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases
Q38070334The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis
Q37369258Translational control of long-lasting synaptic plasticity and memory
Q35031990Tumour necrosis factor-α (TNF-α) and miRNA expression in frontal and temporal neocortex in Alzheimer's disease and the effect of TNF-α on miRNA expression in vitro
Q36551516Unwrapping myelination by microRNAs
Q36251998miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo.
Q30495998miRNA malfunction causes spinal motor neuron disease
Q37535111miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy

Search more.